Navigation Links
SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement
Date:11/5/2009

AUSTIN, Texas, Nov. 5 /PRNewswire/ -- SpineSmith Partners has signed an initial agreement with GenOsteo, Inc. to co-develop a unique scaffold that mimics the structure of natural cancellous bone. Following evaluation of several commercial products by SpineSmith's Research and Development Department, the company believes the GenOsteo scaffold represents a significant advancement in technology that creates a unique and ideal environment for the delivery of adult stem cells for skeletal repair and regeneration. Focused initially on developing fusion applications in conjunction with the use of SpineSmith interbody spinal spacers, SpineSmith believes that the proprietary GenOsteo process is unique and has the potential to provide an optimal cell carrier for several applications in spine, general orthopedics, trauma and plastic and reconstructive surgery.

Dr. James Poser, Vice President of Regenerative Medicine for SpineSmith, and his team will work closely with GenOsteo to bring this product to the market.

"GenOsteo has created an elegant and highly effective material that can be combined with adult stem cells for promoting bone formation. We look forward to collaborating with the scientists at GenOsteo to produce the next generation point-of-care adult stem cell product that will become the preferred fusion product of orthopedic and neurosurgeons," said Poser.

GenOsteo scientists developed the technology and have licensed the rights from the University of Texas at San Antonio. The GenOsteo process produces a calcium phosphate scaffold with uniform porosity, surface and resorption characteristics.

"GenOsteo is delighted to partner with SpineSmith to develop hydroxyapatite-based scaffold technology for optimal delivery of cell-based spinal implant therapies. It represents an ideal marriage of implant design, cell therapy and advanced material science," said Daniel Oh, president of GenOsteo and co-inventor of the technology.

Both companies will be attending the North American Spine Society (NASS) on November 11-14 in San Francisco. Members of the development team will be there to demonstrate and discuss how this unique scaffolding can revolutionize the presentation of cells in spinal fusion. SpineSmith and GenOsteo expect to bring this product to market in late 2010.

About GenOsteo

GenOsteo has developed a bone-like scaffold that is similar to the composition and structure of the inorganic portion of the natural cancellous bone. GenOsteo scaffolds allow the formation or regeneration of functional bone tissues and can be adapted to fit into implants such as with interbody spacers used in spinal fusion. In addition, bony defects resulting from trauma or disease in long bones can be regenerated to provide aesthetics as well as functional restoration by the use of the GenOsteo scaffolds.

About SpineSmith Partners, LP

SpineSmith Partners, LP is dedicated to creating better ways to facilitate and accelerate the healing of spinal disorders through integration of innovative medical devices and biologic technologies. SpineSmith designs, develops, and markets implants and biologics for surgical fixation, correction, and tissue regeneration of the spine. SpineSmith's dedication to a collaborative approach between scientists, engineers and spine surgeons results in the development of truly innovative biological and hardware technologies.

www.spinesmithusa.com

SOURCE SpineSmith Partners


'/>"/>
SOURCE SpineSmith Partners
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
2. Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
3. Emerson Resources Forges Strategic Partnership with Bio Research
4. Public-Private Partnerships Key to Achieving Global Food Security, Says DuPont Leader
5. Diabetics: 3tailer Partners with MyGlucoHealth on World's 1st Blood Glucose Meter with Wireless Bluetooth for Diabetes
6. Professional Pricing Society Announces Educational Partnership with Vendavo -- "PPS Accepting Vendavo Pricing Knowledge Series Awards to Certified Pricing Professional Program"
7. SourceMedical's Therapy Software Partners with FOTO, the Leading Provider of Patient Outcome Surveys
8. Crescendo Biologics Raises GBP4.5 million in Seed-Funding Led by Sofinnova Partners
9. Blue Marble Energy and Bionavitas Announce Partnership to Produce Industrial Biochemicals from Microalgae
10. Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition
11. Abidance Consulting Partners with the FBI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality ... Several trends in analytical testing are being attributed to new regulatory requirements for ...
(Date:10/11/2017)... ... ... is a basic first aid supply for any work environment, but most personal eye wash ... if a dangerous substance enters both eyes? It’s one less decision, and likely quicker response ... piece. , “Whether its dirt and debris, or an acid or alkali, getting anything in ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):